Article Text

Download PDFPDF
Falsified Medicines Directive news: EDQM announce collaboration with the European Medicines Verification Organisation
  1. Richard Price
  1. Correspondence to Richard Price, Department of Policy and Advocacy, European Association of Hospital Pharmacy, 3 Rue Abbe Cuypers, Brussels 1040, Belgium; richard.price{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The European Directorate for the Quality of Medicines & HealthCare (EDQM), an agency of the Council of Europe, has announced a new relationship with the European Medicines Verification Organisation (EMVO). EDQM will in future conduct periodic conformity assessments of the European Medicines Verification System (EMVS) and its governance.

The European Medicines Verification System is the product of the EMVO, a designed solution by five European medicines supply chain organisations to meet the verification and authentification requirements of the 2011 Falsified Medicines Directive. It provides a centralised ‘blueprint’ model that each country can adopt under the governance of ‘national medicines verification organisations’ (NMVOs), which are currently in the process of construction.

EDQM's new role with the system provides a form of external audit for the overall EMVO system ‘to determine whether …

View Full Text